CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

29 hedge funds and large institutions have $18.2M invested in Cymabay Therapeutics in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 8 closing their positions.

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
4
Reduced
8
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$7K -$233K -85,603 -97%
Bank of America
27
Bank of America
North Carolina
$6K +$6K +2,200 New
BIM
28
BlackRock Investment Management
Delaware
$6K +$6K +2,239 New
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1
SFM
30
Sphera Funds Management
Israel
-$1.09M -157,179 Closed
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
-$374K -54,108 Closed
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
-$211K -30,383 Closed
Citadel Advisors
33
Citadel Advisors
Florida
-$183K -26,373 Closed
JG
34
Jefferies Group
New York
-$150K -21,646 Closed
EEG
35
E.E. Geduld
-$138K -20,000 Closed
MC
36
Menta Capital
California
-$127K -18,356 Closed
EGA
37
Eagle Global Advisors
Texas
-$115K -16,630 Closed